Symbols

TMED

T. Rowe Price Health Care ETF·NASDAQ

--(--)

Key Stats

Assets Under Management

16.44MUSD

Fund Flows (1Y)

3.82MUSD

Dividend Yield

0.54%

Discount/Premium to NAV

0.04%

Shares Outstanding

550.00K

Expense Ratio

0.44%

About T. Rowe Price Health Care ETF

Issuer

T. Rowe Price Associates, Inc.

Brand

T. Rowe Price

Home Page

https://www.troweprice.com/personal-investing/tools/fund-research/etf/TMED

Inception Date

Jun 11, 2025

Structure

Open-Ended Fund

Index Tracked

Management Style

Active

Dividend Treatment

Distributes

Distribution Tax Treatment

Qualified dividends

Income Tax Type

Capital Gains

Max ST Capital Gains Rate

39.60%

Max LT Capital Gains Rate

20.00%

Primary Advisor

T. Rowe Price Associates, Inc. (IM)

Distributor

T. Rowe Price Investment Services, Inc.

TMED actively invests in securities of health care companies located mainly in the US but may also include foreign companies as well. Health care companies include a wide range such as biotechnology, pharmaceuticals, products and device providers, and health care service companies. Firms must be classified in the MSCI GICS health care sector. The fund employs a fundamental, bottom-up analysis and can invest in companies across any market capitalization using both growth and value strategies, typically focusing on 100-150 stocks. This includes the use of derivatives related to the fund's investment focus. The funds management team aims to outperform its respective sector index.